Sientra to Participate in Upcoming Virtual Investor Conferences
November 06 2020 - 08:30AM
Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a
diversified medical aesthetics company, today announced that
members of management are scheduled to participate in four upcoming
virtual investor conferences. The Company will participate in
fireside chats at the Stifel 2020 Virtual Healthcare Conference on
Monday, November 16, 2020 and the Stephens Annual Investment
Conference 2020 on Friday, November 20, 2020.
Event: Stifel 2020
Virtual Healthcare ConferenceFormat: Fireside Chat and 1x1
MeetingsDate: Monday, November 16, 2020Time: 6:20 a.m. PT / 9:20
a.m. ET
Event:
11th Annual
Craig-Hallum Alpha Select
ConferenceFormat: 1x1 MeetingsDate: Tuesday, November 17,
2020
Event: Canaccord
Genuity Virtual MedTech & Diagnostics ForumFormat: 1x1
MeetingsDate: Thursday, November 19, 2020
Event:
Stephens Annual
Investment
Conference 2020Format: Fireside
Chat and 1x1 MeetingsDate: Friday, November 20, 2020Time: 7:00 a.m.
PT / 10:00 a.m. ET
Live and archived webcasts of the fireside chats
will be available on the “Investors” section of the Sientra website
at www.sientra.com.
About SientraHeadquartered in
Santa Barbara, California, Sientra is a diversified global medical
aesthetics company and a leading partner to aesthetic physicians.
The Company offers a suite of products designed to make a
difference in patients' lives by enhancing their body image,
growing their self-esteem, and restoring their confidence. Sientra
has developed a broad portfolio of products with technologically
differentiated characteristics, supported by independent laboratory
testing and strong clinical trial outcomes. The Company’s Breast
Products Segment includes its OPUS® breast implants, the first
fifth generation breast implants approved by the FDA for sale in
the United States, its ground-breaking Allox2® breast tissue
expander with patented dual-port and integral drain technology, and
BIOCORNEUM® the #1 performing, preferred and recommended scar gel
of plastic surgeons(*). The Company’s miraDry Segment, comprised of
its miraDry® system, is approved for sale in over 56 international
markets and is the only non-surgical, FDA-cleared device indicated
for the permanent reduction of underarm sweat and hair and may also
reduce odor.
Sientra uses its investor relations website
to publish important information about the Company, including
information that may be deemed material to investors. Financial and
other information about Sientra is routinely posted and
is accessible on the Company’s investor relations website
at www.sientra.com.
(*) Data on file
ContactInvestor Relations805-679-8885
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Sientra (NASDAQ:SIEN)
Historical Stock Chart
From Mar 2023 to Mar 2024